
Selenium-Based Compounds and Nanobiomaterials in Biomedical Applications
- 1st Edition - March 1, 2026
- Editors: Hélder A. Santos, Luigia Serpico
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 3 3 9 7 8 - 3
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 3 9 7 9 - 0
Selenium-based Compounds and Nanobiomaterials in Biomedical Applications delves into the evolving landscape of selenium research and it’s novel uses in biomedical applications… Read more
Purchase options

- Introduces the state-of-the-art in selenium research, and the physiological role of selenium in the human body as an essential micronutrient
- Comprehensively details the newest technologies used in the fabrication of selenium-based nanobiomaterials, including green chemistry procedures, biosynthesis and more
- Reviews the benefits of selenium-based nanobiomaterials and compounds for a range of biomedical applications, – including cancer treatment and drug delivery – highlighting the clinical and translation considerations with the aid of case studies
1. The key role of selenium in human health
2. Right intake/metabolism/biochemical pathways
3. Selenium involvement in physio-pathological processes
4. Organs’ development/functions/diseases (main focuses on: heart, brain, thyroid)
Part II: the redox chemistry selenium and its involvement in biological processes
5. Selenium as redox modulator (and its duality)
6. Selenium status in chronic diseases
7. Se in cancer àSe as anticancer, radio protective agent
8. Selenium in inflammatory and immune response (virus-covid19)
9. Involvement of Se in epigenetics and longevity
Part III: Selenium based materials and biomedical applications
10. Selenium supplementation as powerful diseases prevention tool àsupplementation/cosmetics
11. Se-based materials and their therapeutic applications ànanoparticle/small molecules
12. Clinical trials, future perspectives, and challenges of selenium supplementation and therapy
- Edition: 1
- Published: March 1, 2026
- Language: English
HS
Hélder A. Santos
LS
Luigia Serpico
Luigia has a Bachelor's and a Master’s Degrees in Medical Biotechnology (University of Naples “Federico II”, Italy). She completed a PhD in Chemical Sciences, in the discipline Organic Chemistry, University of Naples “Federico II”, Italy. Her thesis was focused on the design, synthesis and characterization of selenium containing glycoconjugates with antioxidant activity.
Luigia has extensive experience as an industry-based researcher, she has co-founded a start-up in the digital health field and she is co-inventor of two European patents. After her PhD graduation, she was part of a multi-disciplinary research team and, in collaboration with a company, she developed a polymeric system for the transdermal, topical delivery of synthetized antioxidants.
Luigia has recently been awarded a Marie Curie grant, and her current research focus is the development of multi-engineered selenium nanoparticles for gene therapy of BRAF-mutated melanoma.